Natural Capsules Limited — Board Meeting, 13-11-2025: Outcome of Board Meeting
13-11-2025 | 04:50 pm
13-11-2025 | 04:50 pm
Natural Capsules' board approved the financial results for the quarter and half-year. Q2 revenue was ₹45.80 Cr, with a net loss of ₹6.99 Cr. They opted *not* to invest in subsidiary Natural Biogenex's Rights Issue, citing ongoing project cash flow needs.
No comments yet. Be the first to comment!
